Chapter 22. Cholangiocarcinoma

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor9,10,11,12,13,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology14,15,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology13,16,17 and
  4. Yuman Fong MD Professor of Surgery18,19
  1. Ravi S. Chari MD, FRCSC, FACS1,
  2. T. Markley Earl MD2,
  3. Burnett S. Kelly MD3,
  4. Elizabeth I. Johnston MD4,
  5. Mary Kay Washington MD, PhD5,
  6. Christopher D. Anderson MD6,
  7. Stephen J. Meranze MD5,
  8. Laura A. Williams MD7,
  9. Jordan Berlin MD7,
  10. Jayamarx Jayaraman MBBS, MPH5 and
  11. A. Bapsi Chakravarthy MD8

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch22

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

Chari, R. S., Earl, T. M., Kelly, B. S., Johnston, E. I., Washington, M. K., Anderson, C. D., Meranze, S. J., Williams, L. A., Berlin, J., Jayaraman, J. and Chakravarthy, A. B. (2008) Cholangiocarcinoma, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch22

Editor Information

  1. 9

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 10

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 11

    Cancer Research, UK

  4. 12

    Queen Mary University of London, UK

  5. 13

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 14

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 15

    Southern Arizona VA Health Care System, USA

  8. 16

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 17

    University of Oxford, UK

  10. 18

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 19

    Weill Cornell Medical Center, New York, USA

Author Information

  1. 1

    Division of Hepatobiliary, Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, USA

  2. 2

    Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA

  3. 3

    Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

  4. 4

    Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN, USA

  5. 5

    Vanderbilt University Medical Center, Nashville, TN, USA

  6. 6

    Section of Abdominal Transplant Surgery, Washington University in St. Louis, St Louis, MI, USA

  7. 7

    Vanderbilt University, Vanderbilt-Ingram Medical Center, Nashville, TN, USA

  8. 8

    Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • cholangiocarcinoma;
  • primary sclerosing cholangitis;
  • Magnetic resonance cholangiopancreatography (MRCP);
  • preoperative portal vein embolization (PVE);
  • biliary tract cancer and chemotherapy efficacy;
  • traditional chemotherapy - gemcitabine or 5-FU;
  • distal cholangiocarcinomas and pancreatic cancers;
  • intraluminal brachytherapy;
  • intraoperative radiotherapy (IORT);
  • radiofrequency ablation (RFA)

Summary

This chapter contains sections titled:

  • Diagnosis

  • Imaging and Staging

  • Treatment

  • Prognosis and follow-up

  • References